Protective effect of sivelestat sodium (Eraspol®) on postoperative lung dysfunction in patients with type A acute aortic dissection: A pilot study

Journal of Cardiovascular Surgery

Volumn 49, Issue 5, 2008, Pages 627-631

  Nishibe, Toshiya ^a,c   Kondo, Y ^a   Muto, A ^b   Dardik, A ^b   Ohara, Y ^a   Kainuma, M ^a   Takeda, K ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (Japan)

Author keywords

Aneurysm, dissecting; Cardiopulmonary bypass; Circulatory arrest, deep hypothermia induced

Indexed keywords

ERASPOL; OXYGEN; SIVELESTAT; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AORTA DISSECTION; AORTA DISSECTION TYPE A; AORTA SURGERY; ARTERIAL OXYGEN TENSION; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ARREST; HUMAN; HYPOTHERMIA; INFLAMMATION; LEUKOCYTE; LUNG FUNCTION; MALE; PILOT STUDY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RESPIRATORY FAILURE; SURGICAL TECHNIQUE;

ACUTE DISEASE; ANALYSIS OF VARIANCE; ANEURYSM, DISSECTING; AORTIC ANEURYSM, THORACIC; CARDIOPULMONARY BYPASS; CHI-SQUARE DISTRIBUTION; FEMALE; GLYCINE; HUMANS; LEUKOCYTE COUNT; LUNG DISEASES; MALE; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; RESPIRATORY FUNCTION TESTS; SERINE PROTEINASE INHIBITORS; SULFONAMIDES; TREATMENT OUTCOME;

EID: 56049114242     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Coselli JS, Buket S, Djukanovic B. Aortic arch operation: current treatment and results. Ann Thorac Surg 1995;59:19-26.
2. Pansini S, Gagliardotto PV, Pompei E, Parisi F, Bardi G, Castenetto E et al. Early and late risk factors in surgical treatment of acute type A aortic dissection. Ann Thorac Surg 1998;66:779-84.
3. Kawahito K, Adachi H, Yamaguchi A, Ino T. Early and late surgical outcomes of acute type A aortic dissection in patients aged 75 years and older. Ann Thorac Surg 2000;70:1455-9.
4. Svensson LG, Crawford ES, Hess KR, Coselli JS, Raskin S, Shenaq SA et al. Deep hypothermia with circulatory arrest. Determinants of stroke and early mortality in 656 patients. J Thorac Cardiovasc Surg 1993;106:19-28.
5. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-57.
6. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108:636-41.
7. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;105:234-41.
8. Martin WJ, 2nd. Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am Rev Respir Dis 1984;130:209-13.
9. Harlan JM. Leukocyte-endothelial interactions. Blood 1985;65:513-25.
10. Yamazaki T, Ooshima H, Usui A, Watanabe T, Yasuura K. Protective effects of ONO-5046*Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury. Ann Thorac Surg 1999;68:2141-6.
11. Matsuzaki K, Hiramatsu Y, Homma S, Sato S, Shigeta O, Sakakibara Y. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg 2005;80:611-7.
12. Wakayama S, Fukuda I, Suzuki YNK. Neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury after cardiopulmonary bypass in the rabbit endotoxemia model. Ann Thorac Surg 2007;83:153-60.
13. Iba T, Kidokoro A, Fukunaga M, Takuhiro K, Yoshikawa S, Sugimotoa K. Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters. Shock 2006;26:95-8.
14. Ryugo M, Sawa Y, Takano H, Matsumiya G, Iwai S, Ono M et al. Effect of a polymorphonudear elastase inhibitor (sivelestat sodium) on acute lung injury after cardiopulmonary bypass: findings of a double-blind randomized study. Surg Today 2006;36:321-6.
15. Furusawa T, Tsukioka K, Fukui D, Sakaguchi M, Seto T, Terasaki T et al. The effects of a neutrophil elastase inhibitor on the post-operative respiratory failure of acute aortic dissection. Thorac Cardiovasc Surg 2006;54:404-7.
16. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
17. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis 1986;133:218-25.
18. Kubo K, Kobayashi T, Hayano T, Koizumi T, Honda T, Sekiguchi M et al. Effects of ONO-5046, a specific neutrophil elastase inhibitor, on endotoxin-induced lung injury in sheep. J Appl Physiol 194;77:1333-40.
19. Sakamaki F, lshizaka A, Urano T, Sayama K, Nakamura H, Terashima T et al. Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1996;153:391-7.
20. Kawabata K, Hagio T, Matsumoto S, Nakao S, Orita S, Aze Y et al. Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am J Respir Crit Care Med 2000;161:2013-8.
21. Miyazaki Y, Inoue T, Kyi M, Sawada M, Miyake S, Yoshizawa Y. Effects of a neutrophil elastase inhibitor (ONO-5046) on acute pulmonary injury induced by tumor necrosis factor alpha (TNFalpha) and activated neutrophils in isolated perfused rabbit lungs. Am J Respir Crit Care Med 1998;157:89-94.
22. Hagio T, Nakao S, Matsuoka H, Matsumoto S, Kawabata K, Ohno H. Inhibition of neutrophil elastase activity attenuates complement-mediated lung injury in the hamster. Eur J Pharmacol 2001;426:131-8.
23. Takakuma S, Shiba S, Hirasawa H, Ogawa M, Nakajima M. A phase III clinical study of a neutrophil elastase inhibitor; ONO-5046. Rynsho Iyaku 1998;2:289-318.